Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether supplementation 2g/day encapsulated fish oil modifies inflammatory markers in individuals with colorectal cancer in chemotherapy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fish Oil Supplementation in Gastrointestinal Cancer

NCT02699047

Gastrointestinal Cancer Colorectal Cancer Stomach Cancer

UNKNOWN NA

The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer

NCT04699760

Cancer Cachexia Side Effects Quality of Life

COMPLETED PHASE4

Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer

NCT03751384

Compliance Abdominal Cancer

COMPLETED NA

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

NCT01661764

Colorectal Adenomatous Polyps

COMPLETED PHASE2

Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer

NCT01218841

Surgery

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will recruit patients with newly diagnosed colorectal cancer and that has not yet undergone any chemotherapy treatment. Individuals that meet the inclusion criteria are randomized by means of a computer program on two study groups: 1) supplemented Experimental: receive 2g/day supplementation encapsulated fish oil for 9 weeks. 2) No intervention - control: not receive supplementation of fish oil or placebo. Will be assessed the effects of supplementation on the standard profile of cytokine production, nutritional status, and proportion of incorporation of these fatty acids in blood cells (mononuclear and red blood cells).

Blood samples are collected before the start of first chemotherapy and nine weeks later. Supplementation in the experimental group also will start on the first day of chemotherapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fish oil encapsuled

will receive the supplementation of 2 g / day of fish oil encapsulated for 9 weeks

Group Type EXPERIMENTAL

fish oil encapsuled

Intervention Type DIETARY_SUPPLEMENT

2 g/d (4 capsules of 500 mg)for 9 weeks

without supplementation

not will receive supplementation or encapsulated fish oil or placebo

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fish oil encapsuled

2 g/d (4 capsules of 500 mg)for 9 weeks

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

omega-3 encapsuled

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 19 years
* Histopathological diagnosis of colorectal cancer
* Beginning of chemotherapy in the target institution
* Agree to participate in the study \[signature of IC\]

Exclusion Criteria

* Age \<19 years
* Being in palliative care
* Inability to oral intake
* Allergic to the fish and fish products
* Owning with hyperlipidemia requiring drug treatment
* Consumption prior to the study of fish oil or supplements containing omega-3 PUFA
* Being in medical treatment with some nonsteroidal anti-inflammatory
* Have some kind of infection

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No